Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine in Adult Autism
NCT00027404Phase 2Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Sep 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Autism Spectrum Disorder (ASD) comparing Fluoxetine with Placebo (2 arms). Primary endpoint: Yale-Brown Obsessive Compulsive Scale - Compulsion Subscale at 12 weeks. Started Sep 2001; status: completed.
02
Drugs
fluoxetine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00027404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00027404.